Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 54

    1.

    Microbial tolerance in secondary peritonitis is dose dependent.

    Lenz AM, Turina M, Alard P, Gardner SA, Cheadle WG.

    Cell Immunol. 2009;258(1):98-106. Epub 2009 Apr 23.PMID: 19393606 [PubMed - indexed for MEDLINE]Related articles

    2.

    Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

    Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

    PLoS One. 2008;3(12):e3942. Epub 2008 Dec 16.PMID: 19079604 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Antigenic experience dictates functional role of glycogen synthase kinase-3 in human CD4+ T cell responses.

    Garcia CA, Benakanakere MR, Alard P, Kosiewicz MM, Kinane DF, Martin M.

    J Immunol. 2008 Dec 15;181(12):8363-71.PMID: 19050253 [PubMed - indexed for MEDLINE]Related articles

    4.

    APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.

    Manirarora JN, Kosiewicz MM, Parnell SA, Alard P.

    PLoS One. 2008;3(11):e3739. Epub 2008 Nov 17.PMID: 19011680 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta.

    Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M.

    J Immunol. 2008 Nov 15;181(10):6797-802.PMID: 18981097 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. 1997.

    Taylor AW, Alard P, Yee DG, Streilein JW.

    Ocul Immunol Inflamm. 2007 May-Jun;15(3):215-24. No abstract available. PMID: 17613836 [PubMed - indexed for MEDLINE]Related articles

    7.

    A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model.

    Franke DD, Yolcu ES, Alard P, Kosiewicz MM, Shirwan H.

    Mol Immunol. 2007 Apr;44(11):2884-92. Epub 2007 Feb 26.PMID: 17324464 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.

    Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK.

    J Immunol. 2006 Nov 15;177(10):6962-73.PMID: 17082611 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Nitric oxide- and hydrogen peroxide-responsive gene regulation during cell death induction in tobacco.

    Zago E, Morsa S, Dat JF, Alard P, Ferrarini A, Inzé D, Delledonne M, Van Breusegem F.

    Plant Physiol. 2006 Jun;141(2):404-11. Epub 2006 Apr 7.PMID: 16603664 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Benchmarking the CATMA microarray. A novel tool for Arabidopsis transcriptome analysis.

    Allemeersch J, Durinck S, Vanderhaeghen R, Alard P, Maes R, Seeuws K, Bogaert T, Coddens K, Deschouwer K, Van Hummelen P, Vuylsteke M, Moreau Y, Kwekkeboom J, Wijfjes AH, May S, Beynon J, Hilson P, Kuiper MT.

    Plant Physiol. 2005 Feb;137(2):588-601.PMID: 15710687 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.

    Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM.

    J Exp Med. 2005 Jan 3;201(1):127-37.PMID: 15630140 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells.

    Kosiewicz MM, Alard P.

    Immunol Res. 2004;30(2):155-70. Review.PMID: 15477657 [PubMed - indexed for MEDLINE]Related articles

    15.

    Transcript profiling of early lateral root initiation.

    Himanen K, Vuylsteke M, Vanneste S, Vercruysse S, Boucheron E, Alard P, Chriqui D, Van Montagu M, Inzé D, Beeckman T.

    Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5146-51. Epub 2004 Mar 29.PMID: 15051881 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.

    Alard P, Clark SL, Kosiewicz MM.

    Int Immunol. 2003 Aug;15(8):945-53.PMID: 12882832 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.
    19.

    Regulatory T-cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease.

    Tung KS, Agersborg SS, Alard P, Garza KM, Lou YH.

    Immunol Rev. 2001 Aug;182:135-48. Review.PMID: 11722630 [PubMed - indexed for MEDLINE]Related articles

    20.

    Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin requires mast cell degranulation.

    Alard P, Kurimoto I, Niizeki H, Doherty JM, Streilein JW.

    Eur J Immunol. 2001 Jun;31(6):1736-46.PMID: 11385618 [PubMed - indexed for MEDLINE]Related articles

    21.

    Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy.

    Alard P, Thompson C, Agersborg SS, Thatte J, Setiady Y, Samy E, Tung KS.

    J Immunol. 2001 Apr 1;166(7):4363-9.PMID: 11254690 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Neural influences on induction of contact hypersensitivity.

    Streilein JW, Alard P, Niizeki H.

    Ann N Y Acad Sci. 1999 Oct 20;885:196-208. Review.PMID: 10816653 [PubMed - indexed for MEDLINE]Related articles

    23.

    Retargeting T cell-mediated inflammation: a new perspective on autoantibody action.

    Lou YH, Park KK, Agersborg S, Alard P, Tung KS.

    J Immunol. 2000 May 15;164(10):5251-7.PMID: 10799886 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.

    Takeuchi M, Alard P, Verbik D, Ksander B, Streilein JW.

    Immunology. 1999 Dec;98(4):576-83.PMID: 10594691 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    A new concept of skin-associated lymphoid tissue (SALT): UVB light impaired cutaneous immunity reveals a prominent role for cutaneous nerves.

    Streilein JW, Alard P, Niizeki H.

    Keio J Med. 1999 Mar;48(1):22-7. Review.PMID: 10206015 [PubMed - indexed for MEDLINE]Related articles

    28.

    Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.

    Yamada J, Dana MR, Zhu SN, Alard P, Streilein JW.

    Arch Ophthalmol. 1998 Oct;116(10):1351-7.PMID: 9790635 [PubMed - indexed for MEDLINE]Related articles

    29.

    Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity.

    Niizeki H, Alard P, Streilein JW.

    J Immunol. 1997 Dec 1;159(11):5183-6.PMID: 9548453 [PubMed - indexed for MEDLINE]Related articles

    30.

    TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.

    Takeuchi M, Alard P, Streilein JW.

    J Immunol. 1998 Feb 15;160(4):1589-97.PMID: 9469414 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells.

    Taylor AW, Alard P, Yee DG, Streilein JW.

    Curr Eye Res. 1997 Sep;16(9):900-8.PMID: 9288451 [PubMed - indexed for MEDLINE]Related articles

    32.

    On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.

    Takeuchi M, Kosiewicz MM, Alard P, Streilein JW.

    Eur J Immunol. 1997 Jul;27(7):1648-56.PMID: 9247573 [PubMed - indexed for MEDLINE]Related articles

    33.

    High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity.

    Bacci S, Alard P, Dai R, Nakamura T, Streilein JW.

    Eur J Immunol. 1997 Feb;27(2):442-8.PMID: 9045915 [PubMed - indexed for MEDLINE]Related articles

    34.

    The attenuated V60 strain of channel catfish virus possesses a deletion in ORF50 coding for a potentially secreted glycoprotein.

    Vanderheijden N, Alard P, Lecomte C, Martial JA.

    Virology. 1996 Apr 15;218(2):422-6.PMID: 8610472 [PubMed - indexed for MEDLINE]Related articles

    35.

    MHC class II tolerant T cells undergo apoptosis upon re-exposure to tolerogen in vivo.

    Alard P, Levy R, Kosiewicz M, Jones M, Streilein JW.

    Transpl Immunol. 1996 Mar;4(1):76-80.PMID: 8762018 [PubMed - indexed for MEDLINE]Related articles

    36.

    Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice. Microchimerism fails to predict tolerance.

    Alard P, Matriano JA, Socarras S, Ortega MA, Streilein JW.

    Transplantation. 1995 Nov 27;60(10):1125-30.PMID: 7482720 [PubMed - indexed for MEDLINE]Related articles

    37.

    Induction of peripheral T cell tolerance and allo/xenoimmunity.

    Charpentier B, Alard P, Hiesse C, Lantz O.

    Pathol Biol (Paris). 1994 Mar;42(3):237-40. Review.PMID: 8090573 [PubMed - indexed for MEDLINE]Related articles

    38.

    A versatile ELISA-PCR assay for mRNA quantitation from a few cells.

    Alard P, Lantz O, Sebagh M, Calvo CF, Weill D, Chavanel G, Senik A, Charpentier B.

    Biotechniques. 1993 Oct;15(4):730-7.PMID: 8251176 [PubMed - indexed for MEDLINE]Related articles

    39.

    [Mechanism of allograft rejection]

    Lantz O, Alard P, Charpentier B.

    Pathol Biol (Paris). 1993 Jun;41(6):515-20. French. No abstract available. PMID: 8247629 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.

    Kriaa F, Hiesse C, Alard P, Lantz O, Noury J, Charpentier B, Bazin H.

    Transplant Proc. 1993 Feb;25(1 Pt 1):817-9. No abstract available. PMID: 8438496 [PubMed - indexed for MEDLINE]Related articles

    41.

    A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipients.

    Alard P, Lantz O, Perrot JY, Chavanel G, Senik A, Charpentier B.

    Transplantation. 1993 Feb;55(2):277-83.PMID: 8434376 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Current concepts on the alloreactive response]

    Lantz O, Alard P, Charpentier B.

    Nephrologie. 1993;14(1):3-7. French. PMID: 8502347 [PubMed - indexed for MEDLINE]Related articles

    43.

    Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantation.

    Hiesse C, Kriaa F, Alard P, Lantz O, Noury J, Bensadoun H, Benoit G, Charpentier B, Fries D, Bazin H.

    Transpl Int. 1992;5 Suppl 1:S444-7.PMID: 14621841 [PubMed - indexed for MEDLINE]Related articles

    44.

    Allogenic recognition in 1992.

    Lantz O, Alard P, Charpentier B.

    Biomed Pharmacother. 1992;46(2-3):85-90.PMID: 1421042 [PubMed - indexed for MEDLINE]Related articles

    46.

    Comparative molecular modeling of Amphioxus calcium vector protein with calmodulin and troponin C.

    Cox JA, Alard P, Schaad O.

    Protein Eng. 1990 Oct;4(1):23-32.PMID: 2290830 [PubMed - indexed for MEDLINE]Related articles

    47.

    Structural interpretation of the amino acid sequence of a second domain from the Artemia covalent polymer globin.

    Moens L, Van Hauwaert ML, De Smet K, Ver Donck K, Van De Peer Y, Van Beeumen J, Wodak S, Alard P, Trotman C.

    J Biol Chem. 1990 Aug 25;265(24):14285-91.PMID: 2387850 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Decreased lymphokine-activated killer cells in kidney transplant recipients. Correlation with a diminished number of CD3-/NKH1+ cells.

    Alard P, Lantz O, Ramirez A, Perrot JY, Chavanel G, Fries D, Charpentier B, Senik A.

    Transplantation. 1990 Aug;50(2):250-7.PMID: 1696407 [PubMed - indexed for MEDLINE]Related articles

    49.

    Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis.

    Lantz O, Alard P, Ben Aribia MH, Chavanel G, Fries D, Senik A, Charpentier B.

    J Immunol. 1990 May 15;144(10):3748-55.PMID: 2332630 [PubMed - indexed for MEDLINE]Related articles

    50.

    Suppressive phenomena and absence of clonal deletion evidenced by limiting dilution analysis (LDA) of donor-specific IL2 secreting cells (IL2 SC) and cytotoxic precursors (CTLp).

    Lantz O, Alard P, Ben Aribia H, Fries D, Senik A, Charpentier B.

    Transplant Proc. 1989 Feb;21(1 Pt 1):367-8. No abstract available. PMID: 2650150 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...